First patient treated with Medtronic Valiant TAAA Stent Graft System in thoracoabdominal aortic aneurysm study

DUBLIN and SIOUX FALLS, S.D. – February 9, 2016 – Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation’s largest health care systems, today announced the first patient enrolled in a clinical study using the Medtronic Valiant® TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm…

Source: Sanford Health

Full Story:  

About Us